Nasdaq Apgn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq apgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Apgn Today - Breaking & Trending Today

Apexigen, Inc. (NASDAQ:APGN) Short Interest Update

Apexigen, Inc. (NASDAQ:APGN – Get Free Report) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totalling 64,500 shares, a decline of 18.8% from the July 15th total of 79,400 shares. Approximately 0.3% of the shares of the company are sold […] ....

Blackrock Inc , Vanguard Group Inc , Apexigen Inc , Citadel Advisors , Apexigen Company Profile , Get Free Report , Street Corp , Apexigen Daily , Nasdaq Apgn ,

Apexigen (NASDAQ:APGN) versus Catalyst Biosciences (NASDAQ:CBIO) Critical Survey

Apexigen (NASDAQ:APGN – Get Rating) and Catalyst Biosciences (NASDAQ:CBIO – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Volatility and Risk Apexigen has a beta of 3.94, suggesting […] ....

San Carlos , United States , South San Francisco , Apexigen Inc , Catalyst Biosciences Inc , Get Rating , Catalyst Biosciences , Given Apexigen , Catalyst Bioscience , Apexigen Daily , Nasdaq Apgn , Stock Comparison , Stock Analysis ,

Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its

- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in. ....

United States , William Duke , Xiaodong Yang , Bruce Mackle , Apexigen Inc , Columbia University , Securities Exchange , Chief Executive Officer , Securities Act , Securities Exchange Act , Nasdaq Apgn ,

Apexigen (NASDAQ:APGN) Trading Up 3.5%

Apexigen, Inc. (NASDAQ:APGN – Get Rating) shares were up 3.5% on Wednesday . The company traded as high as $0.52 and last traded at $0.52. Approximately 17,221 shares were traded during trading, a decline of 99% from the average daily volume of 2,086,545 shares. The stock had previously closed at $0.50. Analyst Ratings Changes A […] ....

Ef Hutton Acquisition Co , Citadel Advisors , Apexigen Inc , Blackrock Inc , Vanguard Group Inc , Get Rating , Capital Management , Roth Capital , Stock Down , Street Corp , Apexigen Daily , Nasdaq Apgn ,